COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,387 Articles (22,816 medRxiv, 8,571 bioRxiv)

Most recent first Previous |  Page 206: Articles 2051-2060  | Next

Dispersal history of SARS-CoV-2 variants Alpha, Delta, and Omicron (BA.1) in Spain
Gallego-Garcia, P., Hong, S. L., Bollen, N., Dellicour, S., Baele, G., Suchard, M. A., Lemey, P., Posada, D.
10.1101/2024.07.01.24309632 — Posted: 2024-07-02
Awake prone positioning effectiveness in moderate to severe COVID-19 a randomized controlled trial.
Nguyen Thanh, P., Du, D. H., Hai, H. B., Nguyen, N. T., Khoa, L. D. V., Khanh, L. T. T., Tran, L. H. B., Linh, N. T. M., Van, C. T. C., Thao, D. P., Trinh, N. T. D., Kieu, P. T., Truong, N. T., Hoang, V. T., Ngoc, N. T., Vien, T. T. D., Ly, V. T., Khoa, T. D., Beane, A., Anibal, J. T., Thwaites, G., Geskus, R. B., Clifton, D., Dung, N. T. P., Kestelyn, E., Glover, G., Tan, L. V., Yen, L. M., Tung, N. L. N., Dung, N. T., Thwaites, C. L.
10.1101/2024.06.30.24309722 — Posted: 2024-07-01
Trends in Sudden Cardiac Death in Pilots: A Post COVID-19 Challenging Crisis of Global Perspectives (2011-2023)
Borges, J. Y. V.
10.1101/2024.06.29.24309708 — Posted: 2024-07-01
PARP14 mediated SQSTM1/p62 cysteine ADP-ribosylation is counteracted by the SARS-CoV-2 macrodomain
Kubon, D., Leslie Pedrioli, D. M., Hottiger, M. O.
10.1101/2024.06.29.601315 — Posted: 2024-07-01
Differential action modes of Neutrophil Extracellular Trap-targeted drugs define T cell responses in SARS-CoV-2 infection.
Bonilha, C. S., Veras, F. P., Ramos, A. d. S., Gomes, G. F., Lemes, R. M. R., Arruda, E., Alves-Filho, J. C., Cunha, T. M., Cunha, F. d. Q.
10.1101/2024.06.30.601403 — Posted: 2024-07-01
From HHV-6 reactivation to autoimmune reactivity against tight junctions and neuronal antigens, to inflammation, depression, and chronic fatigue syndrome due to Long COVID.
Maes, M., Almulla, A. F., Tang, X., Stoyanova, K., Vojdani, A.
10.1101/2024.06.28.24309682 — Posted: 2024-06-30
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance
Hollister, J., Porter, C., Sprissler, R., Beitel, S. C., Romine, J. K., Uhrlaub, J. L., Grant, L., Yoo, Y. M., Fowlkes, A., Britton, A., Olsho, L. E. W., Newes-Adeyi, G., Fuller, S., Zheng, P. Q., Gaglani, M. G., Rose, S., Dunnigan, K., Naleway, A. L., Gwynn, L., Caban-Martinez, A., Schaefer Solle, N., Tyner, H. L., Philips, A. L., Hegmann, K. T., Yoon, S., Lutrick, K., Burgess, J. L., Ellingson, K. D.
10.1101/2024.06.28.24309655 — Posted: 2024-06-30
Inpatient Burden of COVID-19 in Japan: A Retrospective Cohort Study
Andersen, K. M., Brouillette, M. A., Togo, K., Tanabe, K., Carter, B. T., Kent, M. T., Ding, Y., Curcio, D., Welch, V., McGrath, L. J., Ilyas, B., Ito, S.
10.1101/2024.06.28.24309640 — Posted: 2024-06-30
COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study
Vivaldi, G., Talaei, M., Pfeffer, P. E., Shaheen, S. O., Martineau, A. R.
10.1101/2024.06.28.24309666 — Posted: 2024-06-30
The COVID-19 pandemic in Canadas provinces: mitigation measures and outcomes
Grootendorst, P.
10.1101/2024.06.28.24309653 — Posted: 2024-06-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).